One health wake-up call: London’s river data highlights environmental perils

The largest-ever spatiotemporal monitoring of chemicals/contaminants of emerging concern (CECs) in London waterways.

Clinical data from Boston Scientific and rivals could reshape pulmonary embolism market: analysts

Dive Brief: Catheter-based interventions developed by Boston Scientific, Inari Medical and Penumbra could transform the treatment of pulmonary embolism in the coming years, according to

September 26, 2023

Galecto axes lead candidate in lung disease after PhIIb miss, stock craters

Galecto scrapped development of its lead candidate after the drug missed the primary endpoint in a mid-stage lung disease trial and said it is “evaluating

August 16, 2023

Fibroblast Growth Factor Receptor 4 drugs in development by Therapy Areas, Indications, Stages, MoA, RoA, Molecule Type, and Key Players, 2023

Share this article The report also covers products from therapy areas such as Oncology, Gastrointestinal, and Metabolic Disorders which include the indications Solid Tumor, Hepatocellular

November 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.